Vanguard Group Inc Lyra Therapeutics, Inc. Call Options Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LYRA
# of Institutions
46Shares Held
23.9MCall Options Held
56.6KPut Options Held
33.9K-
Perceptive Advisors LLC New York, NY12.8MShares$85.5 Million0.07% of portfolio
-
Black Rock Inc. New York, NY2.83MShares$19 Million0.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA1.39MShares$9.31 Million0.08% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.06MShares$7.09 Million0.02% of portfolio
-
Adar1 Capital Management, LLC Austin, TX533KShares$3.57 Million0.01% of portfolio
About Lyra Therapeutics, Inc.
- Ticker LYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,826,400
- Market Cap $213M
- Description
- Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...